Ontozry Európska únia - lotyština - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsija - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Maalox 460 mg/400 mg/4,3 ml suspensija iekšķīgai lietošanai Lotyšsko - lotyština - Zāļu valsts aģentūra

maalox 460 mg/400 mg/4,3 ml suspensija iekšķīgai lietošanai

opella healthcare france s.a.s., france - aluminii hydroxidum, magnija hydroxidum - suspensija iekšķīgai lietošanai - 460 mg/400 mg/4,3 ml

Daxocox Európska únia - lotyština - EMA (European Medicines Agency)

daxocox

ecuphar nv - enflicoxib - pretiekaisuma un pretreimatisma līdzekļi - suņi - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Sitagliptin SUN Európska únia - lotyština - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Trittico AC 150 mg ilgstošās darbības tabletes Lotyšsko - lotyština - Zāļu valsts aģentūra

trittico ac 150 mg ilgstošās darbības tabletes

aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a., italy - trazodona hidrohlorīds - ilgstošās darbības tablete - 150 mg